Low Impact of Urinary Cortisol in the Assessment of Hydrocortisone Replacement Therapy.

Haas, C S; Rahvar, A-H; Danneberg, S; Lehnert, H; Moenig, H; Harbeck, B

Haas, C S; Rahvar, A-H; Danneberg, S; Lehnert, H; Moenig, H; Harbeck, B.

Affiliation

Haas CS; Department of Medicine I, University of Luebeck, Luebeck, Germany.
Rahvar AH; Department of Medicine I, University of Luebeck, Luebeck, Germany.
Danneberg S; Department of Medicine I, University of Luebeck, Luebeck, Germany.
Lehnert H; Department of Medicine I, University of Luebeck, Luebeck, Germany.
Moenig H; Department of Medicine I, University of Kiel, Kiel, Germany.
Harbeck B; Department of Medicine I, University of Luebeck, Luebeck, Germany.

Horm Metab Res ; 48(9): 571-4, 2016 Sep.

Article de En | MEDLINE | ID: mdl-27300473

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Hydrocortisone / Insuffisance surrénale / Hormonothérapie substitutive / Anti-inflammatoires Type d'étude: Observational_studies / Prognostic_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Horm Metab Res Année: 2016 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google